Welcome to The Thalheimer Center for Cardio-Oncology

Developments in cancer treatment and care have dramatically improved survival for cancer patients, allowing them to live longer, fuller lives. However, just as these treatments are necessary to eradicate cancer, they can also negatively impact other organ systems, including the cardiovascular system. The mission of the Thalheimer Center for Cardio-Oncology is to relentlessly advance the cardiovascular health in our cancer patients and survivors, and envision a world of longer, healthier lives. Our diverse team of clinicians, physician-scientists, researchers, and trainees within the Cardio-Oncology community at Penn allow us to offer specialized, state-of-the-art cardiovascular care for cancer patients and survivors. Located in Philadelphia, our institution is one of the few in the nation that brings together specialists in both cardiology and oncology to treat and protect your heart prior to, during, and after cancer treatment. For over 15 years, our multidisciplinary team has been caring for cancer patients and survivors. Today, it is possible to find a doctor with a specialty in Cardio-Oncology at multiple Penn Medicine locations. Our cardiologists work closely with the oncologists of the Abramson Cancer Center to provide seamless, integrated care.

Under the leadership of the Thalheimer Center's Director, Dr. Bonnie Ky, MD, MSCE, the Thalheimer Center is driven by core values of excellence; patient-centeredness; innovation; collaboration; and inclusivity. We are tightly aligned with the Abramson Cancer Center's mission to prevent, control, and ultimately cure cancer, our vision is to advance rigorous, impactful, and actionable science; provide highly accessible, empathic, exceptional patient care; and build the next generation of physicians, scientists, and care providers.    

          Donate to the Thalheimer Center for Cardio-Oncology

Joan Thalheimer with Cardio-Oncology Providers under the Thalheimer Center for Cardio-Oncology sign
From left to right: Dr. Rupal O'quinn, Dr. Michael Fradley, Dr. Bénédicte Lefebvre, Dr. Joseph Carver, Joan Thalheimer, Dr. Bonnie Ky, and Dr. Marielle Scherrer-Crosbie.

Thalheimer Center News

  • Congratulations JACC Journals! Monday, July 15, 2024

    All JACC Journals Eligible for Impact Factor Rank Among Top 20 CV Journals Worldwide

    The 2023 JACC Journal Impact Factor Scores, released in June 2024, show that JACC: CardioOncology continues to grow its impact factor with a score of 12 for the year!

  • Congratulations Dr. Vivek Narayan! Monday, May 6, 2024

    Congratulations to Dr. Vivek Narayan and the team for having their work, "Coronary Microvascular Dysfunction in Men with Prostate Cancer Receiving Androgen-Deprivation Therapy" published in the Journal of Clinical Genitourinary Cancer!

    Read here or at the link above: Coronary Microvascular Dysfunction in Men with Prostate Cancer Receiving Androgen-Deprivation Therapy - ScienceDirect

  • Congratulations Ivy Han! Friday, April 19, 2024

    Congratulations to Ivy Han, MS1 working in Dr. Ky's lab, for being selected for the 2024 Stolley Award/Medical Student Summer Research Fellowship in the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania and for being awarded an American Heart Association’s scientific council 2024 Student Scholarship in Cardiovascular Disease!!

Thalheimer Center Events

  • 2024 Global Cardio Oncology Summit

    Join us in Minneapolis, Minnesota on September 22-24, 2024 for this in-person state-of-the-art, comprehensive curriculum that addresses important clinical topics relevant to the cardiovascular health of patients with cancer.

    Together with local and international experts in cardiology and oncology experts will learn the latest research and contemporary practice strategies in prevention, early diagnosis, and management of cardiovascular disease in patients with cancer.

    This meeting will provide a forum for networking and professional collaboration. All presentations will include devoted time for interaction between audience members and presenters.

  • 2nd International Pediatric Cardio-Oncology Conference

    November 8-9, 2024

    Location: Cincinnati, Ohio

    Topics covered included: 

    Emerging therapies in pediatric cardio-oncology, including ICI, targeted therapies, CAR T-cell

    Approach to therapy in patients with cardiotoxicity

    Cardiometabolic syndrome and cardiovascular risk factors in survivors of pediatric cancer

    Cardio-protective strategies in cancer therapy

    Surveillance for cardiotoxicity

    Case presentations and patient discussion with experts in the field of cardio-oncology

  • Thalheimer Center for Cardio-Oncology Symposium

    Join us for the first annual Thalheimer Center for Cardio-Oncology Symposium on March 6, 2025! This symposium will bring together the multi-disciplinary Thalheimer Center for Cardio-Oncology community of physicians, scientists, APPs, PharmDs to share the most current, rigorous cardio-oncology science, foster new, multi-center collaborations in clinically actionable science. This event will take place at the Perelman Center.